INKON Life Technology Co., Ltd. Stock price

Equities

300143

CNE100000XF6

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
8.34 CNY +2.21% Intraday chart for INKON Life Technology Co., Ltd. -6.19% -21.54%
Sales 2023 * 1.5B 207M Sales 2024 * 1.83B 253M Capitalization 5.33B 738M
Net income 2023 * 125M 17.3M Net income 2024 * 178M 24.63M EV / Sales 2023 * 3.56 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.92 x
P/E ratio 2023 *
43.9 x
P/E ratio 2024 *
29.8 x
Employees 2,098
Yield 2023 *
-
Yield 2024 *
-
Free-Float 21.17%
More Fundamentals * Assessed data
Dynamic Chart
INKON Life Technology Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares. CI
INKON Life Technology Co., Ltd. authorizes a Buyback Plan. CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Inkon Life Technology Co., Ltd. Announces Directorate Appointments CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
INKON Life Technology to Set Up Medical Ecological Park for 566 Million Yuan MT
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders. CI
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. agreed to acquire Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders for CNY 87.7 million. CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
INKON Life Technology Co., Ltd. announced that it expects to receive CNY 999.999998 million in funding from Qingdao Yingkang Medical Investment Co., Ltd. CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+2.21%
1 week-6.19%
Current month-2.57%
1 month-5.66%
3 months-21.10%
6 months-19.65%
Current year-21.54%
More quotes
1 week
8.08
Extreme 8.08
9.12
1 month
8.03
Extreme 8.03
9.12
Current year
6.51
Extreme 6.51
10.74
1 year
6.51
Extreme 6.51
13.06
3 years
6.51
Extreme 6.51
29.15
5 years
6.51
Extreme 6.51
29.71
10 years
4.45
Extreme 4.4474
29.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 20-03-31
Director of Finance/CFO 42 20-12-31
Director/Board Member 40 19-10-31
Members of the board TitleAgeSince
Director/Board Member 66 19-05-15
Chairman 54 19-05-22
Director/Board Member 52 19-05-15
More insiders
Date Price Change Volume
24-03-27 8.34 +2.21% 4 683 419
24-03-27 8.16 -2.04% 4,567,000
24-03-26 8.33 -0.36% 4,060,750
24-03-25 8.36 -4.35% 4,476,769
24-03-22 8.74 -2.02% 7,265,902

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.34 CNY
Average target price
12.27 CNY
Spread / Average Target
+47.12%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock INKON Life Technology Co., Ltd. - Shenzhen S.E.